Longboard Pharmaceuticals(LBPH) - 2023 Q4 - Annual Results
Exhibit 99.1 Longboard Pharmaceuticals Reports Full Year 2023 Financial Results and Provides Corporate Updates LA JOLLA, Calif., March 12, 2024 – Longboard Pharmaceuticals, Inc. (Nasdaq: LBPH), a clinical-stage biopharmaceutical company focused on developing novel, transformative medicines for neurological diseases, today provided a corporate update and reported full year 2023 financial results. "I am extremely proud of what our team has accomplished starting with the immense effort that went into the PACIF ...